Clinical studies monitoring circulating and disseminated tumor cells in gastrointestinal cancers
Language English Country Poland Media print
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
24497131
DOI
10.5603/fhc.2013.0037
PII: VM/OJS/J/37097
Knihovny.cz E-resources
- MeSH
- Gastrointestinal Neoplasms blood diagnosis pathology MeSH
- Clinical Trials as Topic * MeSH
- Humans MeSH
- Biomarkers, Tumor blood metabolism MeSH
- Neoplastic Cells, Circulating metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
- Names of Substances
- Biomarkers, Tumor MeSH
Circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) are responsible for the development of metastatic disease, and may also hold the key to determining tailored therapies of advanced cancer disease. Our review summarizes the prognostic significance of the detection of CTCs and DTCs in various gastrointestinal cancers with an overview of their possible use as prognostic biomarkers. This could be used inthe future as a starting point for new clinical trials focusing on the predictive potential of circulating and disseminated tumor cells.
References provided by Crossref.org
Molecular characterization and heterogeneity of circulating tumor cells in breast cancer
Circulating tumor cells in pancreatic cancer patients: enrichment and cultivation
